Literature DB >> 27262459

Efficacy of vacuum-assisted closure therapy on rehabilitation during the treatment for surgical site infection after cardiovascular surgery.

Akihiro Yoshimoto1, Takafumi Inoue2, Masayuki Fujisaki2, Sei Morizumi2, Yoshihiro Suematsu2.   

Abstract

OBJECTIVE: Surgical site infection (SSI) after cardiovascular procedures is a severe complication, potentially leading to high morbidity and mortality. In addition, during the treatment of SSI, rehabilitation is delayed, which can severely impair postoperative recovery. The aim of this study was to assess the effect of vacuum-assisted closure (VAC) therapy on rehabilitation during the treatment of SSI after cardiovascular surgery.
METHODS: From January 2008 to March 2015, 10 patients underwent VAC therapy for SSI after cardiovascular operations. The patient characteristics, duration of VAC therapy, time interval from the implementation of VAC to physical therapy (PT) (T1), ambulation (T2) and walking (T3), functional independent measure (FIM), and maximum consecutive walking capacity (MCWC) were retrospectively analyzed.
RESULTS: Nine patients underwent mid-sternal incision and one patient underwent thoraco-abdominal incision. The mean time interval from the beginning of VAC therapy to PT, ambulation, and walking was 0.38 ± 0.50, 0.63 ± 0.71, and 1.38 ± 1.86 days, respectively. The average FIM was 84.5 ± 14.0 at the beginning of VAC therapy and 106.7 ± 18.5 at the end of VAC therapy (P = 0.000494). On average, MCWC was 52.3 ± 54.6 m at the installation of VAC therapy and 189.7 ± 152.8 m at the completion of VAC therapy (P = 0.0169). FIM and MCWC improvement rate was better in VAC group than non-VAC group although these data are not suitable for statistical analysis because of a small sample size.
CONCLUSIONS: Although further studies are warranted, VAC therapy may have a role in facilitating rehabilitation and improving the prognosis of SSI cases after major cardiovascular operations.

Entities:  

Keywords:  Cardiovascular surgery; Rehabilitation; Surgical site infection; VAC treatment

Mesh:

Year:  2016        PMID: 27262459     DOI: 10.1007/s11748-016-0664-x

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  14 in total

1.  Vacuum-assisted closure with Safetac technology for mediastinitis in patients with a ventricular assist device.

Authors:  Osamu Kinoshita; Takashi Nishimura; Mitsuhiro Kawata; Masahiko Ando; Shunei Kyo; Minoru Ono
Journal:  J Artif Organs       Date:  2010-04-08       Impact factor: 1.731

2.  Clinical outcome of patients with deep sternal wound infection managed by vacuum-assisted closure compared to conventional therapy with open packing: a retrospective analysis.

Authors:  Uwe Fuchs; Armin Zittermann; Benjamin Stuettgen; Arndt Groening; Kazutomo Minami; Reiner Koerfer
Journal:  Ann Thorac Surg       Date:  2005-02       Impact factor: 4.330

3.  Clinical outcome after poststernotomy mediastinitis: vacuum-assisted closure versus conventional treatment.

Authors:  Johan Sjögren; Ronny Gustafsson; Johan Nilsson; Malin Malmsjö; Richard Ingemansson
Journal:  Ann Thorac Surg       Date:  2005-06       Impact factor: 4.330

4.  Negative pressure wound therapy for left ventricular assist device-related mediastinitis: two case reports.

Authors:  Mitsuhiro Kawata; Takashi Nishimura; Yasuhiro Hoshino; Osamu Kinoshita; Motoyuki Hisagi; Masahiko Ando; Tetsuro Morota; Noboru Motomura; Shunei Kyo; Minoru Ono
Journal:  J Artif Organs       Date:  2011-02-24       Impact factor: 1.731

5.  Superficial and deep sternal wound complications: incidence, risk factors and mortality.

Authors:  L Ridderstolpe; H Gill; H Granfeldt; H Ahlfeldt; H Rutberg
Journal:  Eur J Cardiothorac Surg       Date:  2001-12       Impact factor: 4.191

Review 6.  Poststernotomy mediastinitis: a review of conventional surgical treatments, vacuum-assisted closure therapy and presentation of the Lund University Hospital mediastinitis algorithm.

Authors:  Johan Sjögren; Malin Malmsjö; Ronny Gustafsson; Richard Ingemansson
Journal:  Eur J Cardiothorac Surg       Date:  2006-10-23       Impact factor: 4.191

7.  Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee.

Authors:  A J Mangram; T C Horan; M L Pearson; L C Silver; W R Jarvis
Journal:  Am J Infect Control       Date:  1999-04       Impact factor: 2.918

8.  Deep sternal wound infection after cardiac surgery: modality of treatment and outcome.

Authors:  Franz F Immer; Martina Durrer; Kathrin S Mühlemann; Dominique Erni; Brigitta Gahl; Thierry P Carrel
Journal:  Ann Thorac Surg       Date:  2005-09       Impact factor: 4.330

9.  The vacuum-assisted closure system for the treatment of deep sternal wound infections after cardiac surgery.

Authors:  Tatjana M Fleck; Michael Fleck; Reinhard Moidl; Martin Czerny; Rupert Koller; Pietro Giovanoli; Michael J Hiesmayer; Daniel Zimpfer; Ernst Wolner; Martin Grabenwoger
Journal:  Ann Thorac Surg       Date:  2002-11       Impact factor: 4.330

10.  Contemporary outcome of the surgical management of prosthetic graft infection after a thoracic aortic replacement: is there a room to consider vacuum-assisted wound closure as an alternative?

Authors:  Tomoyuki Suzuki; Shunsuke Kawamoto; Naotaka Motoyoshi; Masatoshi Akiyama; Kiichiro Kumagai; Osamu Adachi; Yukihiro Hayatsu; Koki Ito; Satoshi Matsuo; Yoshikatsu Saiki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-07-20
View more
  2 in total

1.  Vacuum-assisted closure therapy combined with bi-pectoral muscle flap for the treatment of deep sternal wound infections.

Authors:  Chao Wang; Jixun Zhang; Zhenzhong Liu
Journal:  Int Wound J       Date:  2019-12-01       Impact factor: 3.315

Review 2.  The use of vacuum-assisted closure in spinal wound infections with or without exposed dura.

Authors:  Robert Lee; Daniel Beder; John Street; Michael Boyd; Charles Fisher; Marcel Dvorak; Scott Paquette; Brian Kwon
Journal:  Eur Spine J       Date:  2018-04-25       Impact factor: 3.134

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.